Benjamin Goldman
St. John Macomb Oakland Hospital, Ascension Providence Hospital
Papers
2
Total Citations
14
H-Index
2
About
Dr. Benjamin Goldman is a urologic surgeon and researcher whose work focuses on optimizing surgical outcomes for patients with kidney cancer, particularly through the use of robotic-assisted techniques. His major contributions center on understanding why robotic partial nephrectomies—kidney-sparing surgeries for small renal masses—sometimes must be converted to more radical, organ-removing procedures. In a pivotal 2024 study (8 citations), Dr. Goldman identified that conversion is most commonly driven by anatomic and oncologic complexity, such as tumor location or size, rather than surgical error. This finding builds on his earlier, multi-institutional analysis (6 citations) using data from the Michigan Urologic Surgery Improvement Collaborative (MUSIC), which pinpointed specific patient and tumor factors that increase conversion risk. By clarifying these predictors, his work helps surgeons better counsel patients and refine preoperative planning, ultimately aiming to preserve more kidneys. Dr. Goldman’s research is notable for its use of large, statewide databases to generate real-world evidence, directly impacting clinical decision-making in urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2